Open Access

Effect of chronic and heavy drug abuse on biological aging

  • Authors:
    • Elena Vakonaki
    • Manolis Tzatzarakis
    • Konstantina Tsiminikaki
    • Despoina Nathena
    • Persefoni Fragkiadaki
    • Katerina Kalliantasi
    • Katerina Kanaki
    • Georgia Vaki
    • Stavros Plaitis
    • Dimitrios Tsoukalas
    • Athanasios Alegakis
    • Demetrios A. Spandidos
    • Aristidis Tsatsakis
  • View Affiliations

  • Published online on: February 5, 2019     https://doi.org/10.3892/wasj.2019.7
  • Pages: 67-73
  • Copyright: © Vakonaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Telomeres are structures of repeated sequences placed at the ends of chromosomes, which play a major role in various cellular processes. Over the past few years, telomere length has been associated with different environmental and physical factors, as well as with a number of diseases, such as cancer. A number of studies have associated telomere length with many substances that the participants have used, such as anxiolytics and hypnotics. The aim of this study was to investigate the association between telomere length and drug abuse. Following the methodology of quantitative fluorescent in situ hybridization (Q‑FISH), we demonstrated that there was a reduction in telomere length in drug abusers. Furthermore, we evaluated this decrease in relation to cell aging and demonstrated that the biological age of drug abusers, particularly the one of opiate users, was by far greater than their chronological age, depending on the difference between the telomere length of abusers and healthy individuals. The findings of this study indicate an association between telomere length and drug abuse, which leads to premature biological aging. The latter warrants further investigation in order to establish this association in different types of drugs with regard to the severity and the chronic abuse of drugs.

References

1 

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): urihttp://www.emcdda.europa.eu/data/stats2017_en.simplehttp://www.emcdda.europa.eu/data/stats2017_en. Accessed January 23,2019.

2 

Tzatzarakis MN, Vakonaki E, Kovatsi L, Belivanis S, Mantsi M, Alegakis A, Liesivuori J and Tsatsakis AM: Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy. J Anal Toxicol. 39:313–320. 2015.PubMed/NCBI View Article : Google Scholar

3 

Diaper AM, Law FD and Melichar JK: Pharmacological strategies for detoxification. Br J Clin Pharmacol. 77:302–314. 2014.PubMed/NCBI View Article : Google Scholar

4 

WHO Expert Committee on Drug Dependence: Thirty-eighth report. In: WHO Technical Report Series. WHO, Switzerland. 2017.

5 

Nestoros JN, Vakonaki E, Tzatzarakis MN, Alegakis A, Skondras MD and Tsatsakis AM: Long lasting effects of chronic heavy cannabis abuse. Am J Addict. 26:335–342. 2017.PubMed/NCBI View Article : Google Scholar

6 

Cheng GL, Zeng H, Leung MK, Zhang HJ, Lau BW, Liu YP, Liu GX, Sham PC, Chan CC, So KF, et al: Heroin abuse accelerates biological aging: A novel insight from telomerase and brain imaging interaction. Transl Psychiatry. 3(e260)2013.PubMed/NCBI View Article : Google Scholar

7 

Ersche KD, Jones PS, Williams GB, Robbins TW and Bullmore ET: Cocaine dependence: A fast-track for brain ageing? Mol Psychiatry. 18:134–135. 2013.PubMed/NCBI View Article : Google Scholar

8 

Bachi K, Sierra S, Volkow ND, Goldstein RZ and Alia-Klein N: Is biological aging accelerated in drug addiction? Curr Opin Behav Sci. 13:34–39. 2017.PubMed/NCBI View Article : Google Scholar

9 

Vakonaki E, Tsiminikaki K, Plaitis S, Fragkiadaki P, Tsoukalas D, Katsikantami I, Vaki G, Tzatzarakis MN, Spandidos DA and Tsatsakis AM: Common mental disorders and association with telomere length. Biomed Rep. 8:111–116. 2018.PubMed/NCBI View Article : Google Scholar

10 

Blackburn EH: Switching and signaling at the telomere. Cell. 106:661–673. 2001.PubMed/NCBI View Article : Google Scholar

11 

de Lange T: Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100–2110. 2005.PubMed/NCBI View Article : Google Scholar

12 

Chan SW and Blackburn EH: New ways not to make ends meet: Telomerase, DNA damage proteins and heterochromatin. Oncogene. 21:553–563. 2002.PubMed/NCBI View Article : Google Scholar

13 

Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature. 345:458–460. 1990.PubMed/NCBI View Article : Google Scholar

14 

Calado RT and Young NS: Telomere diseases. N Engl J Med. 361:2353–2365. 2009.PubMed/NCBI View Article : Google Scholar

15 

Starkweather AR, Alhaeeri AA, Montpetit A, Brumelle J, Filler K, Montpetit M, Mohanraj L, Lyon DE and Jackson-Cook CK: An integrative review of factors associated with telomere length and implications for biobehavioral research. Nurs Res. 63:36–50. 2014.PubMed/NCBI View Article : Google Scholar

16 

McIlrath J, Bouffler SD, Samper E, Cuthbert A, Wojcik A, Szumiel I, Bryant PE, Riches AC, Thompson A, Blasco MA, et al: Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61:912–915. 2001.PubMed/NCBI

17 

Armanios M, Alder JK, Parry EM, Karim B, Strong MA and Greider CW: Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet. 85:823–832. 2009.PubMed/NCBI View Article : Google Scholar

18 

Blasco MA: Telomere length, stem cells and aging. Nat Chem Biol. 3:640–649. 2007.PubMed/NCBI View Article : Google Scholar

19 

Hao LY, Armanios M, Strong MA, Karim B, Feldser DM, Huso D and Greider CW: Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell. 123:1121–1131. 2005.PubMed/NCBI View Article : Google Scholar

20 

Hemann MT, Strong MA, Hao LY and Greider CW: The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 107:67–77. 2001.PubMed/NCBI View Article : Google Scholar

21 

Rajaraman S, Choi J, Cheung P, Beaudry V, Moore H and Artandi SE: Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo. Proc Natl Acad Sci USA. 104:17747–17752. 2007.PubMed/NCBI View Article : Google Scholar

22 

Samper E, Flores JM and Blasco MA: Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Rep. 2:800–807. 2001.PubMed/NCBI View Article : Google Scholar

23 

Yang Z, Ye J, Li C, Zhou D, Shen Q, Wu J, Cao L, Wang T, Cui D, He S, et al: Drug addiction is associated with leukocyte telomere length. Sci Rep. 3(1542)2013.PubMed/NCBI View Article : Google Scholar

24 

Willeit P, Willeit J, Brandstätter A, Ehrlenbach S, Mayr A, Gasperi A, Weger S, Oberhollenzer F, Reindl M, Kronenberg F, et al: Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 30:1649–1656. 2010.PubMed/NCBI View Article : Google Scholar

25 

Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A, Kimura M, Larson MG, Meigs JB, Keaney JF, et al: Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 5:325–330. 2006.PubMed/NCBI View Article : Google Scholar

26 

Fitzpatrick AL, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Walston J, Kimura M and Aviv A: Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 165:14–21. 2007.PubMed/NCBI View Article : Google Scholar

27 

Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P and Parving HH: Telomere length predicts all-cause mortality in patients with type 1 diabetes. Diabetologia. 53:45–48. 2010.PubMed/NCBI View Article : Google Scholar

28 

Olivieri F, Lorenzi M, Antonicelli R, Testa R, Sirolla C, Cardelli M, Mariotti S, Marchegiani F, Marra M, Spazzafumo L, et al: Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction. Atherosclerosis. 206:588–593. 2009.PubMed/NCBI View Article : Google Scholar

29 

Lin TT, Norris K, Heppel NH, Pratt G, Allan JM, Allsup DJ, Bailey J, Cawkwell L, Hills R, Grimstead JW, et al: Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. Br J Haematol. 167:214–223. 2014.PubMed/NCBI View Article : Google Scholar

30 

Gancarcíková M, Zemanová Z, Brezinová J, Berková A, Vcelíková S, Smigová J and Michalová K: The role of telomeres and telomerase complex in haematological neoplasia: The length of telomeres as a marker of carcinogenesis and prognosis of disease. Prague Med Rep. 111:91–105. 2010.PubMed/NCBI

31 

Nzietchueng R, Elfarra M, Nloga J, Labat C, Carteaux JP, Maureira P, Lacolley P, Villemot JP and Benetos A: Telomere length in vascular tissues from patients with atherosclerotic disease. J Nutr Health Aging. 15:153–156. 2011.PubMed/NCBI

32 

Saliques S, Zeller M, Lorin J, Lorgis L, Teyssier JR, Cottin Y, Rochette L and Vergely C: Telomere length and cardiovascular disease. Arch Cardiovasc Dis. 103:454–459. 2010.PubMed/NCBI View Article : Google Scholar

33 

Ma D, Zhu W, Hu S, Yu X and Yang Y: Association between oxidative stress and telomere length in type 1 and type 2 diabetic patients. J Endocrinol Invest. 36:1032–1037. 2013.PubMed/NCBI View Article : Google Scholar

34 

Testa R, Olivieri F, Sirolla C, Spazzafumo L, Rippo MR, Marra M, Bonfigli AR, Ceriello A, Antonicelli R, Franceschi C, et al: Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Diabet Med. 28:1388–1394. 2011.PubMed/NCBI View Article : Google Scholar

35 

Yan J, Yang Y, Chen C, Peng J, Ding H and Wen Wang D: Short leukocyte telomere length is associated with aortic dissection. Intern Med. 50:2871–2875. 2011.PubMed/NCBI View Article : Google Scholar

36 

Wikgren M, Maripuu M, Karlsson T, Nordfjäll K, Bergdahl J, Hultdin J, Del-Favero J, Roos G, Nilsson LG, Adolfsson R and Norrback KF: Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry. 71:294–300. 2012.PubMed/NCBI View Article : Google Scholar

37 

Wolkowitz OM, Jeste DV, Martin AS, Lin J, Daly RE, Reuter C and Kraemer H: Leukocyte telomere length: Effects of schizophrenia, age, and gender. J Psychiatr Res. 85:42–48. 2017.PubMed/NCBI View Article : Google Scholar

38 

Garcia-Rizo C, Fernandez-Egea E, Miller BJ, Oliveira C, Justicia A, Griffith JK, Heaphy CM, Bernardo M and Kirkpatrick B: Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain Behav Immun. 28:49–53. 2013.PubMed/NCBI View Article : Google Scholar

39 

Fernandez-Egea E, Bernardo M, Heaphy CM, Griffith JK, Parellada E, Esmatjes E, Conget I, Nguyen L, George V, Stöppler H, et al: Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull. 35:437–442. 2009.PubMed/NCBI View Article : Google Scholar

40 

Karabatsiakis A, Kolassa IT, Kolassa S, Rudolph KL and Dietrich DE: Telomere shortening in leukocyte subpopulations in depression. BMC Psychiatry. 14(192)2014.PubMed/NCBI View Article : Google Scholar

41 

Boks MP, van Mierlo HC, Rutten BP, Radstake TR, De Witte L, Geuze E, Horvath S, Schalkwyk LC, Vinkers CH, Broen JC, et al: Longitudinal changes of telomere length and epigenetic age related to traumatic stress and post-traumatic stress disorder. Psychoneuroendocrinology. 51:506–512. 2015.PubMed/NCBI View Article : Google Scholar

42 

Ramin C, Wang W, Prescott J, Rosner B, Simon NM, De Vivo I and Okereke OI: A prospective study of leukocyte telomere length and risk of phobic anxiety among women. Psychiatry Res. 230:545–552. 2015.PubMed/NCBI View Article : Google Scholar

43 

Okereke OI, Prescott J, Wong JY, Han J, Rexrode KM and De Vivo I: High phobic anxiety is related to lower leukocyte telomere length in women. PLoS One. 7(e40516)2012.PubMed/NCBI View Article : Google Scholar

44 

Hartmann N, Boehner M, Groenen F and Kalb R: Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress Anxiety. 27:1111–1116. 2010.PubMed/NCBI View Article : Google Scholar

45 

Simon NM, Walton ZE, Bui E, Prescott J, Hoge E, Keshaviah A, Schwarz N, Dryman T, Ojserkis RA, Kovachy B, et al: Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls. Psychoneuroendocrinology. 58:9–22. 2015.PubMed/NCBI View Article : Google Scholar

46 

Czepielewski LS, Massuda R, Panizzutti B, da Rosa ED, de Lucena D, Macêdo D, Grun LK, Barbé-Tuana FM and Gama CS: Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging. Schizophr Res. 174:39–42. 2016.PubMed/NCBI View Article : Google Scholar

47 

Needham BL, Mezuk B, Bareis N, Lin J, Blackburn EH and Epel ES: Depression, anxiety and telomere length in young adults: Evidence from the National Health and Nutrition Examination Survey. Mol Psychiatry. 20:520–528. 2015.PubMed/NCBI View Article : Google Scholar

48 

Imam T, Jitratkosol MH, Soudeyns H, Sattha B, Gadawski I, Maan E, Forbes JC, Alimenti A, Lapointe N, Lamarre V, et al: CIHR Emerging Team Grant on HIV Therapy and Aging: CARMA: Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants. J Acquir Immune Defic Syndr. 60:495–502. 2012.PubMed/NCBI View Article : Google Scholar

49 

Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD and Cawthon RM: Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA. 101:17312–17315. 2004.PubMed/NCBI View Article : Google Scholar

50 

Wolkowitz OM, Epel ES, Reus VI and Mellon SH: Depression gets old fast: Do stress and depression accelerate cell aging? Depress Anxiety. 27:327–338. 2010.PubMed/NCBI View Article : Google Scholar

51 

Furumoto K, Inoue E, Nagao N, Hiyama E and Miwa N: Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci. 63:935–948. 1998.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

March 2019
Volume 1 Issue 2

Print ISSN: 2632-2900
Online ISSN:2632-2919

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Vakonaki, E., Tzatzarakis, M., Tsiminikaki, K., Nathena, D., Fragkiadaki, P., Kalliantasi, K. ... Tsatsakis, A. (2019). Effect of chronic and heavy drug abuse on biological aging . World Academy of Sciences Journal, 1, 67-73. https://doi.org/10.3892/wasj.2019.7
MLA
Vakonaki, E., Tzatzarakis, M., Tsiminikaki, K., Nathena, D., Fragkiadaki, P., Kalliantasi, K., Kanaki, K., Vaki, G., Plaitis, S., Tsoukalas, D., Alegakis, A., Spandidos, D. A., Tsatsakis, A."Effect of chronic and heavy drug abuse on biological aging ". World Academy of Sciences Journal 1.2 (2019): 67-73.
Chicago
Vakonaki, E., Tzatzarakis, M., Tsiminikaki, K., Nathena, D., Fragkiadaki, P., Kalliantasi, K., Kanaki, K., Vaki, G., Plaitis, S., Tsoukalas, D., Alegakis, A., Spandidos, D. A., Tsatsakis, A."Effect of chronic and heavy drug abuse on biological aging ". World Academy of Sciences Journal 1, no. 2 (2019): 67-73. https://doi.org/10.3892/wasj.2019.7